Sinovac Biotech R&D Spending Growth & History (SVA)
Sinovac Biotech's r&d spending was $216.2M for fiscal 2025.
View full Sinovac Biotech company overviewSinovac Biotech annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $216.2M | −$54.5M | −20.13% |
| 2024 | 2024-12-31 | $270.7M | −$79.5M | −22.71% |
| 2023 | 2023-12-31 | $350.2M | −$128.5M | −26.84% |
| 2022 | 2022-12-31 | $478.7M | $326.0M | +213.49% |
| 2021 | 2021-12-31 | $152.7M | $103.9M | +213.16% |
| 2020 | 2020-12-31 | $48.8M | $24.5M | +101.04% |
| 2019 | 2019-12-31 | $24.3M | $2.3M | +10.70% |
| 2018 | 2018-12-31 | $21.9M | $1.4M | +6.94% |
| 2017 | 2017-12-31 | $20.5M | $7.8M | +61.99% |
| 2016 | 2016-12-31 | $12.6M | $3.2M | +33.28% |
| 2015 | 2015-12-31 | $9.5M | −$1.4M | −13.21% |
| 2014 | 2014-12-31 | $10.9M | $2.8M | +34.52% |
| 2013 | 2013-12-31 | $8.1M | −$8.9M | −52.31% |
| 2012 | 2012-12-31 | $17.0M | $8.0M | +89.23% |
| 2011 | 2011-12-31 | $9.0M | $499,204 | +5.87% |
| 2010 | 2010-12-31 | $8.5M | $4.1M | +93.11% |
| 2009 | 2009-12-31 | $4.4M | — | — |
Sinovac Biotech r&d spending trends
Over the last five fiscal years, Sinovac Biotech's r&d spending increased from $48.8M to $216.2M, a change of $167.4M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sinovac Biotech source filings ↗